These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 35388357)

  • 1. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook.
    Fan Y; Xue H; Zheng H
    J Hepatocell Carcinoma; 2022; 9():233-263. PubMed ID: 35388357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.
    Tella SH; Kommalapati A; Mahipal A; Jin Z
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress in Systemic Therapy for Hepatocellular Cancer (HCC).
    Ghaziani TT; Dhanasekaran R
    Curr Treat Options Gastroenterol; 2021 Jun; 19(2):351-368. PubMed ID: 35530750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic therapy of liver cancer.
    Demir T; Lee SS; Kaseb AO
    Adv Cancer Res; 2021; 149():257-294. PubMed ID: 33579425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic targeted and immunotherapy for advanced hepatocellular carcinoma.
    Cersosimo RJ
    Am J Health Syst Pharm; 2021 Jan; 78(3):187-202. PubMed ID: 33211092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions.
    Weinmann A; Galle PR
    Curr Oncol; 2020 Nov; 27(Suppl 3):S152-S164. PubMed ID: 33343209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCC and Molecular Targeting Therapies: Back to the Future.
    Rinaldi L; Vetrano E; Rinaldi B; Galiero R; Caturano A; Salvatore T; Sasso FC
    Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment options for hepatocellular carcinoma.
    Eugen K
    Klin Onkol; 2020; 33(Supplementum 3):20-25. PubMed ID: 33213161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic therapy for advanced hepatocellular carcinoma: targeted therapies.
    Tella SH; Kommalapati A; Mahipal A
    Chin Clin Oncol; 2021 Feb; 10(1):10. PubMed ID: 32434345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy in Advanced Hepatocellular Carcinoma.
    Javan H; Dayyani F; Abi-Jaoudeh N
    Semin Intervent Radiol; 2020 Dec; 37(5):466-474. PubMed ID: 33328702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for the treatment of hepatocellular carcinoma.
    Ayoub WS; Jones PD; Yang JD; Martin P
    Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
    Su GL; Altayar O; O'Shea R; Shah R; Estfan B; Wenzell C; Sultan S; Falck-Ytter Y
    Gastroenterology; 2022 Mar; 162(3):920-934. PubMed ID: 35210014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigm shift in the treatment options of hepatocellular carcinoma.
    Su TH; Hsu SJ; Kao JH
    Liver Int; 2022 Aug; 42(9):2067-2079. PubMed ID: 34515412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.
    Kudo M
    Liver Cancer; 2020 Dec; 9(6):640-662. PubMed ID: 33442538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma.
    Rimassa L; Wörns MA
    Liver Int; 2020 Aug; 40(8):1800-1811. PubMed ID: 32432830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapies for hepatocellular carcinoma: the present and the future.
    Celsa C; Giuffrida P; Stornello C; Grova M; Spatola F; Rizzo GEM; Busacca A; Cannella R; Battaglia S; Cammà C; Cabibbo G
    Recenti Prog Med; 2021 Feb; 112(2):110-116. PubMed ID: 33624623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations.
    Storandt MH; Mahipal A; Tella SH; Kommalapati A; Jin Z
    J Hepatocell Carcinoma; 2022; 9():1187-1200. PubMed ID: 36471742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular therapies for HCC: Looking outside the box.
    Faivre S; Rimassa L; Finn RS
    J Hepatol; 2020 Feb; 72(2):342-352. PubMed ID: 31954496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date.
    Tella SH; Mahipal A; Kommalapati A; Jin Z
    Onco Targets Ther; 2019; 12():10335-10342. PubMed ID: 31819517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on Systemic Therapy for Hepatocellular Carcinoma.
    Ntellas P; Chau I
    Am Soc Clin Oncol Educ Book; 2024 Jan; 44():e430028. PubMed ID: 38175973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.